International Journal of Medical and Pharmaceutical Research
2025, Volume-6, Issue-4 : 187-256 doi: 10.5281/zenodo.16416907
Original Article
A Study on Predictors of Outcome Following Radio-Cephalic Arteriovenous Fistula Creation in Patients with Chronic Renal Failure
 ,
 ,
 ,
 ,
 ,
Published
July 19, 2025
Abstract

Background: Radio-cephalic arteriovenous fistula (RC-AVF), particularly in the non-dominant limb, is widely regarded as the first choice for vascular access in hemodialysis. However, its success rate tends to decline in elderly patients and those with multiple comorbid conditions. Therefore, thorough preoperative assessment and vigilant postoperative observation are essential to address issues related to fistula maturation. This study was conducted to identify the various factors that influence the success of arteriovenous fistula creation.

Methods: This prospective study enrolled patients aged between 20 and 65 years diagnosed with chronic kidney disease, who had not undergone any prior RC-AVF procedures. The study period ranged from February 1, 2021, to January 31, 2022. Multiple variables—preoperative, intraoperative, and postoperative—were evaluated for their potential effect on fistula outcomes. All AVF surgeries were performed using an end-to-side anastomosis technique with 7-0 prolene suture applied via interrupted sutures.

Results: Among 250 enrolled patients, the highest fistula success rate (84%) was recorded in the 20–30 years age group. This was followed by 78% success rates in the 31–40 and 41–50 years groups. Male patients had a better success rate (61%) compared to female patients (39%). Additionally, a positive association was observed between successful fistula creation and the diameters of both the radial artery and cephalic vein.

Conclusion: Effective maturation of arteriovenous fistulas is significantly linked to ongoing postoperative evaluation. For optimal outcomes, clinical monitoring should begin intraoperatively and be sustained throughout the postoperative phase.

Recommended Articles
Loading Image...
Volume-6, Issue-4
Citations
1535 Views
213 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved